Clinical Trial Update: Dexmedetomidine Intra Venous Arthroplasty [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intravenous dexmedetomidine as an adjunct during primary total knee arthroplasty has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of Knee

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: CMC Ambroise Paré | Conditions: Primary Total Knee Arthroplasty | Phase 3 | Status: COMPLETED